Frequently Asked Questions
The market is segmented based on Segmentation, By Product (Tetracycline, Penicillin, Sulfonamide, Macrolide, Cephalosporin, Fluoroquinolone, Lincosamides, Cephalosporins), Mode of Delivery (Premixes, Oral Powder, Injection, Others), Animal Type (Food-producing Animals, Companion Animals) – Industry Trends and Forecast to 2031.
.
The Global Animal Antibiotics Antimicrobials Market size was valued at USD 4.88 USD Billion in 2023.
The Global Animal Antibiotics Antimicrobials Market is projected to grow at a CAGR of 4.1% during the forecast period of 2024 to 2031.
The major players operating in the market include Boehringer Ingelheim International GmbH, Zoetis, Elanco, Merck & Co. , Phibro Animal Health Corporation, Virbac, Vetoquinol, HIPRA, Ceva, Dechra, Kyoritsuseiyaku Corporation, CHINA ANIMAL HUSBANDRY GROUP, Endovac Animal Health, Zydus Group, Indian Immunologicals Pvt. , UCBVET Saúde e Bem Estar Animal, American Reagent , Neogen Corporation, Huvepharma, Ayurvet, Ashish Life Science, Inovet Group, Lutim Pharma Private Limited, ECO Animal Health Ltd,.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
